Advertisement
Commentary| Volume 76, ISSUE 1, P4-5, July 01, 2014

Blunted Dopamine Release as a Biomarker for Vulnerability for Substance Use Disorders

      Imaging of the striatal dopamine system continues to dominate studies using positron emission tomography (PET) in substance use disorders (SUD). A key reason for this is the stability of the findings: most studies imaging the dopamine D2 family of receptors (D2R) and stimulant-induced dopamine release show blunting of striatal dopamine transmission in subjects with addiction. This phenotype is seen across SUDs, including cocaine, nicotine, alcohol, opiate, and methamphetamine. Reduced binding at the D2R persists independently of many clinical factors, and this effect is maintained following days to months of abstinence. The functional implications of blunted striatal dopamine transmission in the pathophysiology of addiction are becoming more evident, as shown by animal and human studies, such as that reported in this issue of Biological Psychiatry by Casey et al. (
      • Casey K.F.
      • Benkelfat C.
      • Cherkasova M.V.
      • Baker G.B.
      • Dagher A.
      • Leyton M.
      Reduced dopamine response to amphetamine in subjects at ultra-high risk for addiction.
      ).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Casey K.F.
        • Benkelfat C.
        • Cherkasova M.V.
        • Baker G.B.
        • Dagher A.
        • Leyton M.
        Reduced dopamine response to amphetamine in subjects at ultra-high risk for addiction.
        Biol Psychiatry. 2014; 76: 23-30
        • Trifilieff P.
        • Martinez D.
        Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity.
        Neuropharmacology. 2014; 76: 498-509
        • Willuhn I.
        • Burgeno L.M.
        • Groblewski P.A.
        • Phillips P.E.
        Excessive cocaine use results from decreased phasic dopamine signaling in the striatum.
        Nat Neurosci. 2014; 17: 704-709
        • Quintanilla M.E.
        • Bustamante D.
        • Tampier L.
        • Israel Y.
        • Herrera-Marschitz M.
        Dopamine release in the nucleus accumbens (shell) of two lines of rats selectively bred to prefer or avoid ethanol.
        Eur J Pharmacol. 2007; 573: 84-92
        • Volkow N.D.
        • Wang G.J.
        • Fowler J.S.
        • Thanos P.
        • Logan J.
        • Gatley S.J.
        • et al.
        Brain DA D2 receptors predict reinforcing effects of stimulants in humans: Replication study.
        Synapse. 2002; 46: 79-82
        • Volkow N.D.
        • Wang G.J.
        • Begleiter H.
        • Porjesz B.
        • Fowler J.S.
        • Telang F.
        • et al.
        High levels of dopamine D2 receptors in unaffected members of alcoholic families: Possible protective factors.
        Arch Gen Psychiatry. 2006; 63: 999-1008
        • Morgan D.
        • Grant K.A.
        • Gage H.D.
        • Mach R.H.
        • Kaplan J.R.
        • Prioleau O.
        • et al.
        Social dominance in monkeys: Dopamine D2 receptors and cocaine self-administration.
        Nat Neurosci. 2002; 5: 169-174
        • Martinez D.
        • Greene K.
        • Broft A.
        • Kumar D.
        • Liu F.
        • Narendran R.
        • et al.
        Lower level of endogenous dopamine in patients with cocaine dependence: Findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion.
        Am J Psychiatry. 2009; 166: 1170-1177
        • Schneider S.
        • Peters J.
        • Bromberg U.
        • Brassen S.
        • Miedl S.F.
        • Banaschewski T.
        • et al.
        Risk taking and the adolescent reward system: A potential common link to substance abuse.
        Am J Psychiatry. 2012; 169: 39-46
        • Peters J.
        • Bromberg U.
        • Schneider S.
        • Brassen S.
        • Menz M.
        • Banaschewski T.
        • et al.
        Lower ventral striatal activation during reward anticipation in adolescent smokers.
        Am J Psychiatry. 2011; 168: 540-549

      Linked Article